Aclaris Therapeutics, Inc. (ACRS)

NASDAQ: ACRS · Real-Time Price · USD

3.030

-0.020 (-0.66%)

Mar 3, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Identifying and Developing Tnnovative Therapies	7.83M	18.72M	-	-	-
Identifying and Developing Tnnovative Therapies Growth	-58.19%	-	-	-	-
Contract Research	-	-	19.58M	17.01M	13.45M
Contract Research Growth	-	-	15.13%	26.46%	0.96%
Therapeutics	-	-	28.21M	25.36M	932.00K
Therapeutics Growth	-	-	11.27%	2620.60%	33.91%
Intersegment Elimination	-	-	-16.54M	-12.61M	-7.62M
Total	7.83M	18.72M	31.25M	29.75M	6.76M
Total Growth	-58.19%	-40.09%	5.03%	340.05%	4.30%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	7.83M	18.72M	31.25M	29.75M	6.76M
United States Growth	-58.19%	-40.09%	5.03%	340.05%	4.30%
Total	7.83M	18.72M	31.25M	29.75M	6.76M
Total Growth	-58.19%	-40.09%	5.03%	340.05%	4.30%

Source: S&P Global Market Intelligence.